Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease
The FORD model can be used to predict group 3 PH in both IPF patients and non-IPF ILD patients. It could serve as a tool for ILD patient selection for right heart catheterization as well as an enrichment tool for clinical trials targeting the pulmonary vasculature.
Authors
- Ambalavanan Arunachalam (ORCID: https://orcid.org/0000-0002-0363-7889)
- Christopher S. King (ORCID: https://orcid.org/0000-0003-3101-319X)
- Abhimanyu Chandel (ORCID: https://orcid.org/0000-0003-4879-1983)
- Steven D. Nathan (ORCID: https://orcid.org/0000-0002-6270-1617)
- Rade Tomic (ORCID: https://orcid.org/0000-0003-2394-1287)
- Min Jee Kim (ORCID: https://orcid.org/0000-0003-0073-2079)
- Ho Cheol Kim (ORCID: https://orcid.org/0000-0002-3262-0672)
- Malek Shawabkeh (ORCID: https://orcid.org/0000-0002-9287-6063)
Institutions
- Northwestern University (US)
- Ulsan College (KR)
- Uniformed Services University of the Health Sciences (US)
- Inova Fairfax Hospital (US)
- Asan Medical Center (KR)
- University of Ulsan (KR)
Publication Details
- Journal
- Lung
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1007/s00408-024-00783-2
- Citations
- 3
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.56